photo
Speaker

Avnish Kapoor, PHD

DIRECTOR, EMERGING TECHNOLOGY & INNOVATION - CAMBRIDGE, ELI LILLY AND COMPANY
Cambridge, Massachusetts, United States
Avnish is currently a member of the Emerging Technology and venture team in corporate business development at Eli Lilly. His main areas of focus include genome medicine approaches including gene editing/therapy and new drug discovery platforms. Prior to joining the group, Avnish spend 2 years in Lilly Oncology drug discovery leading small molecule projects. Prior to joining Lilly Avnish spent 3 years at Novartis Institute of Biomedical Research, Cambridge as a member of Oncology discovery group.

Avnish received his PhD in Biomedical Research from Mount Sinai School of Medicine, NY and his postdoctoral training at MD Anderson Cancer Center.
Speaking In
11:00 AM - 12:00 PM (EST)
Tuesday, February 16
Frequently altered driver genes in cancer, such as RAS, TP53 and MYC, are attractive targets for…